Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Barbara Eichhorst, Moritz Fürstenau, Michael Hallek

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 482–489.

https://doi.org/10.1182/hematology.2019000070

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.

https://doi.org/10.1182/hematology.2019000367

Published: 2019

Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.

https://doi.org/10.1182/asheducation-2018.1.213

Published: 2018

Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.

https://doi.org/10.1182/asheducation-2018.1.185

Published: 2018

Journal Articles

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

Gregory W. Roloff, Elizabeth A. Griffiths

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 35–44.

https://doi.org/10.1182/asheducation-2018.1.35

Published: 2018

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Novel approaches to therapy in CML

Ravi Bhatia

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 115–120.

https://doi.org/10.1182/asheducation-2017.1.115

Published: 2017

Journal Articles

Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond

Claire N. Harrison, Donal P. McLornan

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 489–497.

https://doi.org/10.1182/asheducation-2017.1.489

Published: 2017

Journal Articles

Uncoding the genetic heterogeneity of myelodysplastic syndrome

R. Coleman Lindsley

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 447–452.

https://doi.org/10.1182/asheducation-2017.1.447

Published: 2017

Journal Articles

Looking forward: novel therapeutic approaches in chronic and advanced phases of myelofibrosis

John Mascarenhas

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 329–339.

https://doi.org/10.1182/asheducation-2015.1.329

Published: 2015

Journal Articles

Therapeutic targeting of microenvironment in follicular lymphoma

Grzegorz S. Nowakowski, Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 169–173.

https://doi.org/10.1182/asheducation-2014.1.169

Published: 2014

Journal Articles

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Charles G. Mullighan

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 174–180.

https://doi.org/10.1182/asheducation-2014.1.174

Published: 2014

Journal Articles

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Clive S. Zent, W. Richard Burack

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 119–124.

https://doi.org/10.1182/asheducation-2014.1.119

Published: 2014

Journal Articles

Biology of BM failure syndromes: role of microenvironment and niches

Sophia R. Balderman, Laura M. Calvi

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 71–76.

https://doi.org/10.1182/asheducation-2014.1.71

Published: 2014

Journal Articles

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

Richard F. Schlenk, Hartmut Döhner

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 324–330.

https://doi.org/10.1182/asheducation-2013.1.324

Published: 2013

Journal Articles

Primary Prophylaxis in Sickle Cell Disease: Is It Feasible? Is It Effective?

Alexis A. Thompson

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 434–439.

https://doi.org/10.1182/asheducation-2011.1.434

Published: 2011

Journal Articles

Management of Myelofibrosis

Alessandro M. Vannucchi

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 222–230.

https://doi.org/10.1182/asheducation-2011.1.222

Published: 2011

Journal Articles

Many Multiple Myelomas: Making More of the Molecular Mayhem

Marta Chesi, P. Leif Bergsagel

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 344–353.

https://doi.org/10.1182/asheducation-2011.1.344

Published: 2011

Journal Articles

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

Jan A. Burger

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 96–103.

https://doi.org/10.1182/asheducation-2011.1.96

Published: 2011

NARROW

Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Molecular profiling and management of mantle cell lymphoma

Clonal dynamics in chronic lymphocytic leukemia

Where does PD-1 blockade fit in HL therapy?

Where to start? Upfront therapy for follicular lymphoma in 2018

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Novel approaches to therapy in CML

Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond

Uncoding the genetic heterogeneity of myelodysplastic syndrome

Looking forward: novel therapeutic approaches in chronic and advanced phases of myelofibrosis

Therapeutic targeting of microenvironment in follicular lymphoma

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Biology of BM failure syndromes: role of microenvironment and niches

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

Primary Prophylaxis in Sickle Cell Disease: Is It Feasible? Is It Effective?

Management of Myelofibrosis

Many Multiple Myelomas: Making More of the Molecular Mayhem

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only